Alpha Sense BI

FEBRUARY 6, 2024

Within the ever-evolving realm of the life sciences industry , fast-paced healthcare investment research plays a crucial role in providing timely insights on valuable opportunities for financial investors.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

MARCH 21, 2024

Expert networks are a critical tool for market intelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. One common misconception is the view that expert perspectives may introduce a potential risk for bias in the research process.

Primary Research 59

Primary Research Due Diligence SWOT Pharmaceutical 59

Alpha Sense BI

FEBRUARY 3, 2023

Without an official system to check an organization’s commitment to its ESG policies, many shareholders and investors are doing their due diligence through fact-checking. timber, natural pharmaceuticals) and services (i.e., In fact, biodiversity attrition can also severely hinder a company’s bottom line.

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

Alpha Sense BI

DECEMBER 12, 2023

Industry nuances, company culture, leadership styles, competitor interactions—these are facets you can’t necessarily uncover by researching numbers and figures, yet they significantly impact whether or not two companies have the right synergies to succeed. Navigating the cultural challenges around M&A integration is a delicate process.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

APRIL 12, 2024

AlphaSense, a leading artificial intelligence (AI)-based market intelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Similarly, expert calls fill particular roles. If you’re going to force me into TPU, that’s like locking me in.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

DECEMBER 15, 2023

According to Precedence Research , the AI market within the healthcare sector is projected to surpass $20.6 In silico trials, powered by AI simulations, researchers can forecast the efficacy and safety profiles of new drugs before they reach human trials. billion in 2023.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52

Alpha Sense BI

MARCH 13, 2024

This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59